NFGCM
AGN

Norman Fields Gottscho Capital Management’s Allergan Inc AGN Stock Holding History

Norman Fields Gottscho Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,825
Closed -$420K – 83
2016
Q3 		$420K Buy
+1,825
New +$420K 0.28% 53

Other funds holding AGN

FIM
Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
LCP
Legacy Capital Partners Milwaukee, Wisconsin $304M AUM 20.42% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $139M AUM
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

Norman Fields Gottscho Capital Management's AGN Position: Q4 2016 in Review

Norman Fields Gottscho Capital Management sold out of Allergan Inc (AGN) in Q4 2016, closing a stake of 1,825 shares — an estimated $420K sold.

Norman Fields Gottscho Capital Management first reported a position in AGN in Q3 2016 and held it in 1 quarter. The position peaked at $420K in Q3 2016. 14 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Norman Fields Gottscho Capital Management reported no remaining Allergan Inc position as of Q4 2016 after selling out during the quarter.
  • Norman Fields Gottscho Capital Management sold 1,825 Allergan Inc shares in Q4 2016, an estimated $420K.
  • Norman Fields Gottscho Capital Management first reported a position in Allergan Inc in Q3 2016 and held it in 1 quarter.
  • Norman Fields Gottscho Capital Management's Allergan Inc position peaked at $420K in Q3 2016.
  • 14 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2016.

Based on Norman Fields Gottscho Capital Management's 13F filing for Q4 2016, filed 4 Jan 2017.